Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran
Mostafa Akbariqomi, Mahboobeh Sadat Hosseini, Jamal Rashidiani, et al.
Diabetes Research and Clinical Practice (2020) Vol. 169, pp. 108467-108467
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial
Gholamreza Farnoosh, Mostafa Akbariqomi, Taleb Badri, et al.
Archives of Medical Research (2021) Vol. 53, Iss. 1, pp. 79-85
Open Access | Times Cited: 80
Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
Stavroula Kastora, Manisha Patel, Ben Carter, et al.
Endocrinology Diabetes & Metabolism (2022) Vol. 5, Iss. 3
Open Access | Times Cited: 65
The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
George El-Arif, Antonella Farhat, Shaymaa Khazaal, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6945-6945
Open Access | Times Cited: 62
The clinical features and outcomes of diabetes patients infected with COVID-19: a systematic review and meta-analysis comprising 192,693 patients
Kai Liu, Shu Liu, Tingting Xu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications
Kiran Ramzan, Sameen Shafiq, Iqra Raees, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 789-789
Open Access | Times Cited: 33
Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
Sian Bradley, Maciej Banach, Negman Alvarado, et al.
Journal of Diabetes (2021) Vol. 14, Iss. 2, pp. 144-157
Open Access | Times Cited: 41
Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Hossein Aghamollaei, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174193-174193
Open Access | Times Cited: 40
Interaction Between SARS-CoV-2 and Pathogenic Bacteria
Parvindokht Fazel, Hamid Sedighian, Elham Behzadi, et al.
Current Microbiology (2023) Vol. 80, Iss. 7
Open Access | Times Cited: 15
Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
Hamid Mirjalili, Seyed Alireza Dastgheib, Seyed Hossein Shaker, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 905-917
Open Access | Times Cited: 31
Case fatality and mortality rates, socio‐demographic profile, and clinical features of COVID‐19 in the elderly population: A population‐based registry study in Iran
Elham Davtalab Esmaeili, Ali Fakhari, Behrouz Naghili, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2126-2132
Open Access | Times Cited: 22
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 563-563
Open Access | Times Cited: 17
Molecular Docking Investigation of Antiviral Herbal Compounds as Potential Inhibitors of SARS-CoV-2 Spike Receptor
Soleyman Fallah, Mohammad Bayati, Ali Najafi, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 11, Iss. 5, pp. 12916-12924
Open Access | Times Cited: 21
COVID-19 and diabetes in 2020: a systematic review
Farideh Javid, Fadi Abdul Waheed, Nisa Zainab, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement
Hadi Esmaeili Gouvarchin Ghaleh, Abdolkarim Hosseini, Hossein Aghamollaei, et al.
Zeitschrift für Naturforschung C (2021) Vol. 77, Iss. 1-2, pp. 37-42
Closed Access | Times Cited: 18
Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis
Hoimonti Debi, Zarin Tasnim Itu, Mohammad Tohidul Amin, et al.
Expert Review of Endocrinology & Metabolism (2021) Vol. 17, Iss. 1, pp. 83-93
Open Access | Times Cited: 17
Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
Tales Lyra de Oliveira, Igor Santana de Melo, Léia Cardoso-Sousa, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 14
COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran
Maryam Peimani, Fatemeh Bandarian, Nazli Namazi, et al.
Journal of Diabetes & Metabolic Disorders (2022) Vol. 21, Iss. 1, pp. 61-68
Open Access | Times Cited: 9
The Prognostic Role of Metabolic and Endocrine Parameters for the Clinical Severity of COVID-19
Shokoufeh Bonakdaran, Parvin Layegh, Solmaz Hasani, et al.
Disease Markers (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 7
Influence of Fasting Plasma Glucose Level on Admission of COVID-19 Patients: A Retrospective Study
Yingying Zhao, Huichun Xing
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 6
SARS-CoV-2 detection by targeting four loci of viral genome using graphene oxide and gold nanoparticle DNA biosensor
Arman Amani Babadi, Shahrooz Rahmati, Rafieh Fakhlaei, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Melatonin as a complementary and prophylactic agent against COVID‐19 in high‐risk populations: A narrative review of recent findings from clinical and preclinical studies
Abdolkarim Hosseini, Taleb Badri, Hadi Esmaeili Gouvarchin Ghaleh, et al.
Fundamental and Clinical Pharmacology (2022) Vol. 36, Iss. 6, pp. 918-929
Open Access | Times Cited: 5
Predictors of New-Onset Diabetes in Hospitalized Patients with SARS-CoV-2 Infection
Iulia Făgărășan, Adriana Rusu, Maria Cristea, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13230-13230
Open Access | Times Cited: 4
The Predictive Role of Artificial Intelligence-Based Chest CT Quantification in Patients with COVID-19 Pneumonia
István Szabó, Judit Simon, Chiara Nardocci, et al.
Tomography (2021) Vol. 7, Iss. 4, pp. 697-710
Open Access | Times Cited: 5
Diabetes and COVID-19 in Congolese patients
Henriette Poaty, Guy Emergence Poaty, Gilbert Ndziessi, et al.
African Health Sciences (2021) Vol. 21, Iss. 3, pp. 1100-1106
Open Access | Times Cited: 4
The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients
Arezoo Fallah, Hamid Sedighian, Elham Behzadi, et al.
Microbial Pathogenesis (2022) Vol. 174, pp. 105888-105888
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top